HER2-positive breast cancer: cotargeting to overcome treatment resistance

Zagami, P; Bielo, LB; Nicolò, E; Curigliano, G

Zagami, P (通讯作者)，Univ Milan, Dept Oncol & Hematooncol, Milan, Italy.;Zagami, P (通讯作者)，Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.;Zagami, P (通讯作者)，European Inst Oncol IEO IRCCS, Div Early Drug Dev Innovat Therapies, Via G Ripamonti 435, I-20141 Milan, Italy.

CURRENT OPINION IN ONCOLOGY, 2023; 35 (6): 461

Abstract

Purpose of review The introduction in clinical practice of anti-HER2 agents changed the prognosis of patients with HER2-positive (HER2+) breast cancer......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索